Obefazimod Trend 2026

Obefazimod is an investigational oral therapy designed for moderate-to-severe ulcerative colitis. It works by modulating sphingosine-1-phosphate receptors to reduce gut inflammation. Primarily benefiting adults with inadequate response to conventional treatments, this once-daily pill offers a promising alternative to biologics, aiming to achieve and maintain remission with a convenient, non-invasive administration route.